(1 - 7 von 7
)
BioVersys' second drug candidate enters clinical trials
www.startupticker.ch
— ... faster-acting and active against Eto-Pto- and INH-resistant strains,” said Sergio Lociuro, Chief Scientific Officer of BioVersys. › news
sortiert nach Relevanz / Datum